HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bassem Sadek Selected Research

Pyrilamine (Mepyramine)

1/2017The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats.
10/2016The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats.
1/2016The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bassem Sadek Research Topics

Disease

15Epilepsy (Aura)
01/2021 - 09/2013
8Cognitive Dysfunction
01/2022 - 10/2016
6Autistic Disorder (Autism)
06/2021 - 01/2018
6Alzheimer Disease (Alzheimer's Disease)
12/2020 - 10/2014
6Memory Disorders (Memory Loss)
03/2020 - 01/2016
5Schizophrenia (Dementia Praecox)
06/2021 - 10/2014
5Narcolepsy
06/2021 - 10/2014
4Amnesia (Dissociative Amnesia)
12/2020 - 01/2016
4Seizures (Absence Seizure)
01/2020 - 09/2013
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 10/2016
3Brain Diseases (Brain Disorder)
01/2022 - 01/2018
3Ulcer
01/2019 - 01/2013
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
05/2022 - 10/2016
2Hyperglycemia
12/2021 - 09/2020
2Insulin Resistance
12/2021 - 09/2020
2Neoplasms (Cancer)
08/2021 - 01/2016
2Autism Spectrum Disorder
06/2021 - 10/2019
2Inflammation (Inflammations)
01/2021 - 01/2013
2Nervous System Diseases (Neurological Disorders)
11/2019 - 10/2014
2Alcoholism (Alcohol Abuse)
11/2015 - 07/2013
1Psoriasis (Pustulosis Palmaris et Plantaris)
04/2022
1Multiple Sclerosis
04/2022
1Cardiovascular Diseases (Cardiovascular Disease)
04/2022
1Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome)
01/2022
1Diabetes Mellitus
12/2021
1Pain (Aches)
01/2021
1Neuralgia (Stump Neuralgia)
12/2020
1Dyslipidemias (Dyslipidemia)
09/2020
1Type 2 Diabetes Mellitus (MODY)
09/2020
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2020
1Status Epilepticus (Complex Partial Status Epilepticus)
11/2019
1Neuroinflammatory Diseases
10/2019
1Stomach Ulcer (Gastric Ulcer)
01/2019
1Body Weight (Weight, Body)
01/2018
1Synucleinopathies
01/2018
1Parkinson Disease (Parkinson's Disease)
01/2018
1Disorders of Excessive Somnolence (Hypersomnia)
10/2016
1Neurobehavioral Manifestations
10/2016
1Hyperlipidemias (Hyperlipidemia)
01/2016
1Diabetic Cardiomyopathies
01/2016
1Hypertension (High Blood Pressure)
01/2016

Drug/Important Bio-Agent (IBA)

19Histamine H3 Receptors (Histamine H3 Receptor)IBA
02/2021 - 07/2013
10Histamine (Histamine Dihydrochloride)FDA Link
01/2022 - 07/2013
7Pharmaceutical PreparationsIBA
05/2022 - 01/2013
7LigandsIBA
02/2021 - 09/2013
6Neurotransmitter Agents (Neurotransmitter)IBA
06/2021 - 01/2018
6Dizocilpine Maleate (Dizocilpine)IBA
12/2020 - 01/2016
6Anticonvulsants (Antiepileptic Drugs)IBA
03/2020 - 09/2013
5Acetylcholine (Acetylcholine Chloride)FDA Link
06/2021 - 10/2019
4EsterasesIBA
06/2020 - 10/2019
4imidazoleIBA
01/2019 - 09/2013
4pitolisantIBA
01/2017 - 06/2014
3Dopamine (Intropin)FDA LinkGeneric
06/2021 - 01/2017
3PhytochemicalsIBA
01/2021 - 01/2016
3Valproic Acid (Depakote)FDA LinkGeneric
06/2020 - 01/2018
3Pentylenetetrazole (Metrazol)IBA
03/2020 - 10/2018
3Dinoprostone (PGE2)FDA Link
01/2019 - 01/2013
3Donepezil (Aricept)FDA LinkGeneric
01/2018 - 10/2016
3Pyrilamine (Mepyramine)FDA Link
01/2017 - 01/2016
3zolantidineIBA
01/2017 - 01/2016
2Insulin (Novolin)FDA Link
12/2021 - 09/2020
2Ethanol (Ethyl Alcohol)IBA
01/2019 - 11/2015
2Scopolamine (Hyoscine)FDA Link
01/2017 - 10/2016
2N-Methylaspartate (NMDA)IBA
10/2016 - 01/2016
2Phenytoin (Dilantin)FDA LinkGeneric
06/2014 - 09/2013
1Dimethyl FumarateIBA
04/2022
1Histamine H3 AntagonistsIBA
01/2022
1EnzymesIBA
12/2021
1Monoterpenes (Monoterpenoids)IBA
12/2021
1Proteins (Proteins, Gene)FDA Link
12/2021
1EndocannabinoidsIBA
08/2021
1Analgesics (Analgesic Drugs)IBA
12/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2020
1Fibric Acids (Fibrates)IBA
09/2020
1Malondialdehyde (Propanedial)IBA
03/2020
1gamma-Aminobutyric Acid (GABA)IBA
03/2020
1Superoxide DismutaseIBA
03/2020
1Aminobutyrates (Aminobutyric Acid)IBA
03/2020
1Glutathione (Reduced Glutathione)IBA
03/2020
1CatalaseIBA
03/2020
1Glutamic Acid (Glutamate)FDA Link
03/2020
1Proto-Oncogene Proteins c-fos (FRAs)IBA
03/2020
1Neuroprotective AgentsIBA
11/2019
1Pilocarpine (Ocusert)FDA LinkGeneric
11/2019
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2019
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2019
1Plant ExtractsIBA
01/2018
1SynucleinsIBA
01/2018
1histamine H3R antagonist 2-18IBA
01/2018
1Glycine Receptors (Glycine Receptor)IBA
12/2017
1Aripiprazole (Abilify)FDA Link
01/2017
1Cholinergic Antagonists (Anticholinergics)IBA
10/2016
1Cholinergic Agents (Cholinergics)IBA
10/2016
1UW-MD-72 compoundIBA
10/2016
1Cisplatin (Platino)FDA LinkGeneric
01/2016
1Promethazine (Promet)FDA LinkGeneric
01/2015
1Organophosphorus CompoundsIBA
01/2015
1Histamine Antagonists (Antihistamines)IBA
01/2015

Therapy/Procedure

3Therapeutics
04/2022 - 01/2020
1Glycemic Control
01/2016